Delivery Order SPE2DB22D2006-SPE2DB25FW2PX
- Not listed
- This is a $3,391.99 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of LUMIGAN 0.01% eye drops, a specialty ophthalmic medication, in support of federal healthcare programs. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $1,775.80 Firm Fixed Price Delivery Order is for the procurement of LUMIGAN 0.01% Eye Drops 5ML. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both entities are registered in the System for Award...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, with a ceiling value of $3,635.40. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of April 10, 2025. This contract award is not associated with a set-aside designation, indicating...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.22, is for the delivery of LUMIGAN 0.01% eye drops in 5ml bottles. The award is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,361.88 firm fixed-price contract is for the delivery of LUMIGAN 0.01% eye drops, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,741.16, is for the supply of LUMIGAN 0.01% eye drops in 5 ML containers. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LUMIGAN 0.01% eye drops in 5ml quantities. The $2,471.04 fixed-price contract was awarded by the Defense Logistics Agency (DLA) on June 5, 2024, with a completion date of June 6, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,592.84, is for the delivery of LUMIGAN 0.01% eye drops in 5ml vials. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of LUMIGAN 0.01% eye drops in 5ml containers. The contract is a Delivery Order with a Firm Fixed Price of $9,539.84 and an ultimate completion date of November 19, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- This federal contract award, valued at $3,631.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMIGAN 0.01% eye drops, a specialty pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of July 17, 2024. It is not designated with a set-aside requirement,...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2PXDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,914.76, is for the delivery of LUMIGAN 0.01% eye drops 5ML. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 7/17/25 |